Literature DB >> 8640533

Current status of structure-activity relationships of platinum anticancer drugs: activation of the trans geometry.

N Farrell1.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8640533

Source DB:  PubMed          Journal:  Met Ions Biol Syst        ISSN: 0161-5149


× No keyword cloud information.
  17 in total

1.  Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.

Authors:  K Lemma; J Berglund; N Farrell; L I Elding
Journal:  J Biol Inorg Chem       Date:  2000-06       Impact factor: 3.358

Review 2.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

3.  Study of the interaction of DNA with cisplatin and other Pd(II) and Pt(II) complexes by atomic force microscopy.

Authors:  G B Onoa; G Cervantes; V Moreno; M J Prieto
Journal:  Nucleic Acids Res       Date:  1998-03-15       Impact factor: 16.971

4.  Biophysical studies on the stability of DNA intrastrand cross-links of transplatin.

Authors:  Jana Kasparkova; Victoria Marini; Vendula Bursova; Viktor Brabec
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

5.  Different apoptotic effects of [Pt(O,O'-acac)(γ-acac)(DMS)] and cisplatin on normal and cancerous human epithelial breast cells in primary culture.

Authors:  Carla Vetrugno; Antonella Muscella; Francesco Paolo Fanizzi; Luca Giulio Cossa; Danilo Migoni; Sandra Angelica De Pascali; Santo Marsigliante
Journal:  Br J Pharmacol       Date:  2014-09-05       Impact factor: 8.739

6.  DNA damage responses in cancer stem cells: Implications for cancer therapeutic strategies.

Authors:  Qi-En Wang
Journal:  World J Biol Chem       Date:  2015-08-26

7.  A potent cytotoxic photoactivated platinum complex.

Authors:  Fiona S Mackay; Julie A Woods; Pavla Heringová; Jana Kaspárková; Ana M Pizarro; Stephen A Moggach; Simon Parsons; Viktor Brabec; Peter J Sadler
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-19       Impact factor: 11.205

8.  DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.

Authors:  Olga Novakova; Jana Kasparkova; Jaroslav Malina; Giovanni Natile; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

9.  Promotion of DNA strand breaks, interstrand cross-links and apoptotic cell death in A2780 human ovarian cancer cells by transplatinum planar amine complexes.

Authors:  Sheena M Aris; David A Gewirtz; John J Ryan; Kenneth M Knott; Nicholas P Farrell
Journal:  Biochem Pharmacol       Date:  2007-02-28       Impact factor: 5.858

10.  Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.

Authors:  Carlson Alexander; A Nithyakumar; M Wilson Bosco Paul; N Arockia Samy
Journal:  J Biol Inorg Chem       Date:  2018-06-14       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.